Dr. Reddy’s forced to stop Suboxone generic rollout amid Indivior patent dispute

Only days after Dr. Reddy’s won a generic approval to Indivior’s top drug-the opioid addiction treatment Suboxone Film-a patent spat between the drugmakers is forcing the company to halt its copycat rollout. A U.S. court has issued a temporary restraining order against Dr. Reddy’s from making further sales after the Indian generics firm launched “at risk” on Friday.

Categories: News Feed Tags: Tags: , ,

PM’s comment on generic drugs a bitter pill for doctors

Prime Minister Narendra Modi’s comment that doctors prescribe only branded medicines because of their nexus with pharmaceutical companies has not gone down well with the medical fraternity. The Indian Medical Association (IMA) has issued a statement saying the PM’s comment, made in London, harms the image of Indian doctors and will fracture the doctor-patient relationship.

Categories: News Feed Tags: Tags: ,

How critics say drug companies play “games” to stave off generic competitors

Lawmakers are considering a bill to address what President Trump called a top priority in his State of the Union speech: lowering prescription drug prices. Critics say some drug companies who want to hold onto their exclusive sales of a brand-name drug – and their profits – are playing games to stave off generic competitors, leaving patients out in the cold.

Categories: News Feed Tags: Tags: ,